Search

Search Constraints

You searched for: Issue Volume 32(2022)Supplement 3

Search Results

63. 20/#1057 Integrated profiling of a prospective endometrial cancer organoid biobank reveals high heterogeneity. (4th December 2022)

64. 21/#810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative. (4th December 2022)

66. 23/#722 Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies. (4th December 2022)

67. 24/#263 Cost study of plasmajet surgical device versus conventional cytoreductive surgery in advanced-stage ovarian cancer patients. (4th December 2022)

68. 26/#534 The impact of utilization indocyanine green for anastomotic perfusion assessment on the rate of diverting ileostomy in patients with advanced ovarian cancer. (4th December 2022)

69. 28/#262 Dose-dense, weekly paclitaxel and carboplatin with or without bevacizumab, in metastatic or recurrent cervical carcinoma (final analysis of JCOG1311). (4th December 2022)